Cargando…

Intestinal Ultrasound Is the Ideal Patient-Centric, Point-of-Care Tool for Clinical Decision Making in the Inflammatory Bowel Disease Practice

Detalles Bibliográficos
Autores principales:	Dolinger, Michael Todd, Kayal, Maia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246577/ https://www.ncbi.nlm.nih.gov/pubmed/37292104 http://dx.doi.org/10.1093/crocol/otad029

Ejemplares similares

Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making
por: Dolinger, Michael T, et al.
Publicado: (2023)

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
por: Saleh, Adam, et al.
Publicado: (2023)

The use of ultrasound in inflammatory bowel disease
por: Kucharzik, Torsten, et al.
Publicado: (2017)

Telenutrition for Inflammatory Bowel Disease: A Tipping Point for Dietary Wellness
por: Elamin, Sami, et al.
Publicado: (2021)

Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee
por: Kellar, Amelia, et al.
Publicado: (2022)

A Full Ranking for Decision Making Units Using Ideal and Anti-Ideal Points in DEA
por: Barzegarinegad, A., et al.
Publicado: (2014)

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines
por: Hernández, Vicent, et al.
Publicado: (2012)

Management of cutaneous disorders related to inflammatory bowel disease
por: Pellicer, Zaira, et al.
Publicado: (2012)

Human-centric decision-making models for social sciences
por: Guo, Peijun, et al.
Publicado: (2014)

Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization
por: St-Pierre, Joëlle, et al.
Publicado: (2023)

Rheumatological manifestations in inflammatory bowel disease
por: Voulgari, Paraskevi V.
Publicado: (2011)

The history of genetics in inflammatory bowel disease
por: Ek, Weronica E., et al.
Publicado: (2014)

Intestinal Ultrasound in Inflammatory Bowel Disease: A Valuable and Increasingly Important Tool
por: Frias-Gomes, Catarina, et al.
Publicado: (2021)

Intestinal Ultrasound in Inflammatory Bowel Disease: A Novel and Increasingly Important Tool
por: Lin, Wei-Chen, et al.
Publicado: (2023)

Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin
por: Derwa, Yannick, et al.
Publicado: (2018)

Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal
por: Mukherjee, Mahua, et al.
Publicado: (2020)

Endocrine and metabolic manifestations in inflammatory bowel disease
por: Tigas, Stelios, et al.
Publicado: (2012)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Familial and ethnic risk in inflammatory bowel disease
por: Santos, Maria Pia Costa, et al.
Publicado: (2018)

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

Bile Acid Signaling in Inflammatory Bowel Diseases
por: Fiorucci, Stefano, et al.
Publicado: (2020)

Psychological factors associated with inflammatory bowel disease
por: Eugenicos, M P, et al.
Publicado: (2021)

It’s complicated: criteria for policy decisions for the clinical integration of genome-scale sequencing for reproductive decision making
por: Wilfond, Benjamin S, et al.
Publicado: (2015)

Nerve biopsy: Current indications and decision tools
por: Nathani, Dev, et al.
Publicado: (2021)

The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021
por: Skamnelos, Alexandros, et al.
Publicado: (2021)

An overview of lipid abnormalities in patients with inflammatory bowel disease
por: Agouridis, Aris P., et al.
Publicado: (2011)

Clostridium difficile infection in patients with inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2011)

Manipulating bone disease in inflammatory bowel disease patients
por: Miheller, Pal, et al.
Publicado: (2013)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe
por: Arias-Loste, Maria Teresa, et al.
Publicado: (2012)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

Diagnosis and treatment of anemia in patients with inflammatory bowel disease
por: Mücke, Victoria, et al.
Publicado: (2017)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
por: Vaidy, Katherine, et al.
Publicado: (2020)

Delivering patient‐centered care through shared decision making in overactive bladder
por: Paudel, Roshan, et al.
Publicado: (2022)

Update on current applications of proteomic in the study of inflammatory bowel disease
por: Roda, Giulia, et al.
Publicado: (2012)

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer
por: Jauregui-Amezaga, Aranzazu, et al.
Publicado: (2016)

Adipokines and the role of visceral adipose tissue in inflammatory bowel disease
por: Karrasch, Thomas, et al.
Publicado: (2016)

Diagnosis and natural history of preclinical and early inflammatory bowel disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
por: Solitano, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_994q125b9t5g46637vtmeb345r